You are here:

CC Diagnostics

Back to overview

Developing early stage cervical cancer diagnostics based on novel epigenetic markers

CC Diagnostics belongs to the fund:

Carduso Capital B.V.">

Carduso Capital participates in technology companies that are preferably based on the know-how represented in and originating from the Groningen science cluster in and around the University of Groningen (RUG) and the ...

View all the funds from the IFG